Analyst Terence Flynn works at MORGAN STANLEY and is focused on the Healthcare sector with 464 price targets and ratings documented since 2012 spanning on 28 stocks. Previously, Terence Flynn worked at GOLDMAN SACHS. Analyst's average stock valuation to be materialised ratio is 72.79% with an average time for price targets to be met of 222.39 days.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 17-Nov-2022.
Terence Flynn best performing recommendations are on CELG.
The best stock recommendation documented was for CELG at 1/2/2019. The price target of $71 was fulfilled within 1 day with a profit of $4.36 (6.54%) receiving and performance score of 65.43.
Average potential price target upside